ASH-话题@MedSci

#ASH#

242篇内容 | 1849人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2176326, encodeId=a31721e632686, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a> <a href='/topic/show?id=da43108980d9' target=_blank style='color:#2F92EE;'>#米托蒽醌脂质体#</a>, objectTitle=国际声音丨2023 ASH米托蒽醌脂质体多项血液领域研究成果精彩亮相！, objectType=article, longId=801014, objectId=49f88010140a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-leading-a-medical-team-at-hospital-DQZSHGT.jpg, objectUrl=/article/show_article.do?id=49f88010140a, replyNumber=0, likeNumber=37, createdTime=2023-12-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=49f88010140a, moduleTitle=国际声音丨2023 ASH米托蒽醌脂质体多项血液领域研究成果精彩亮相！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49f88010140a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1301337, encodeId=8a89130133e34, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器, objectType=article, longId=739786, objectId=e3bae39786a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3bae39786a2, replyNumber=0, likeNumber=50, createdTime=2022-09-19, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3bae39786a2, moduleTitle=TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3bae39786a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301336, encodeId=80461301336a9, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=PLoS One：缘何瘦子也会得NASH-HCC？反式脂肪、胆固醇和果糖含量高的不健康饮食或是关键！, objectType=article, longId=737052, objectId=9c26e37052cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c26e37052cc, replyNumber=0, likeNumber=37, createdTime=2022-08-28, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c26e37052cc, moduleTitle=PLoS One：缘何瘦子也会得NASH-HCC？反式脂肪、胆固醇和果糖含量高的不健康饮食或是关键！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c26e37052cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301335, encodeId=d31d1301335f2, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Chediak-Higashi综合征：症状与体征、病因、流行病学、诊断和治疗, objectType=article, longId=736405, objectId=8096e3640585, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8096e3640585, replyNumber=0, likeNumber=28, createdTime=2022-08-21, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8096e3640585, moduleTitle=Chediak-Higashi综合征：症状与体征、病因、流行病学、诊断和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8096e3640585)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301334, encodeId=acda13013344f, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, objectType=article, longId=728015, objectId=c099e2801596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c099e2801596, replyNumber=0, likeNumber=35, createdTime=2022-05-29, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c099e2801596, moduleTitle=FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c099e2801596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301333, encodeId=4e46130133323, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2021：二线 Axicabtagene Cilouleucel 治疗复发/难治DLBCL，疗效更佳, objectType=article, longId=292794, objectId=003b292e949c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=003b292e949c, replyNumber=0, likeNumber=44, createdTime=2021-12-28, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=003b292e949c, moduleTitle=ASH 2021：二线 Axicabtagene Cilouleucel 治疗复发/难治DLBCL，疗效更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=003b292e949c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301332, encodeId=feb713013325f, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=武田在美国血液学会(ASH)第63届年会上发布可促进血液病和肿瘤患者治疗的新研究成果, objectType=article, longId=221842, objectId=bf7022184289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf7022184289, replyNumber=0, likeNumber=37, createdTime=2021-12-12, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf7022184289, moduleTitle=武田在美国血液学会(ASH)第63届年会上发布可促进血液病和肿瘤患者治疗的新研究成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf7022184289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301331, encodeId=af1f1301331ac, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Radiology：MRI，为NASH患者治疗反应的早期评估提供了强有力的预测指标！, objectType=article, longId=220023, objectId=d59422002301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d59422002301, replyNumber=0, likeNumber=56, createdTime=2021-11-11, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d59422002301, moduleTitle=Radiology：MRI，为NASH患者治疗反应的早期评估提供了强有力的预测指标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d59422002301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301330, encodeId=8b441301330e0, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=NEJM：拉尼兰诺治疗NASH的疗效, objectType=article, longId=218986, objectId=c47421898697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c47421898697, replyNumber=0, likeNumber=40, createdTime=2021-10-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c47421898697, moduleTitle=NEJM：拉尼兰诺治疗NASH的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c47421898697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301329, encodeId=8967130132954, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, objectType=article, longId=218971, objectId=bfc82189e193, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfc82189e193, replyNumber=0, likeNumber=0, createdTime=2021-10-22, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfc82189e193, moduleTitle=Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfc82189e193)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301328, encodeId=986a130132863, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+, objectType=article, longId=218656, objectId=6f2121865698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f2121865698, replyNumber=0, likeNumber=27, createdTime=2021-10-17, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f2121865698, moduleTitle=史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f2121865698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301327, encodeId=918e130132e8c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=50万人数据：预防心肌代谢性疾病只能看DASH和地中海饮食？中国饮食模式也能！, objectType=article, longId=217055, objectId=b89621e055ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b89621e055ff, replyNumber=0, likeNumber=35, createdTime=2021-09-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b89621e055ff, moduleTitle=50万人数据：预防心肌代谢性疾病只能看DASH和地中海饮食？中国饮食模式也能！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b89621e055ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301326, encodeId=0cc613013267c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=JACC：DASH膳食与钠摄入量对心脏损伤/劳损/炎症生物标志物的影响, objectType=article, longId=212213, objectId=b1df212213f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1df212213f8, replyNumber=0, likeNumber=37, createdTime=2021-06-04, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1df212213f8, moduleTitle=JACC：DASH膳食与钠摄入量对心脏损伤/劳损/炎症生物标志物的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1df212213f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301325, encodeId=4302130132519, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=Pain Physician：Ashi针灸治疗 VS. 局部麻醉注射治疗腹肌筋膜疼痛综合征的疗效对比, objectType=article, longId=209947, objectId=058220994ed8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=058220994ed8, replyNumber=0, likeNumber=0, createdTime=2021-04-15, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=058220994ed8, moduleTitle=Pain Physician：Ashi针灸治疗 VS. 局部麻醉注射治疗腹肌筋膜疼痛综合征的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=058220994ed8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301324, encodeId=a3e713013241c, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠, objectType=article, longId=208218, objectId=1fc520821824, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fc520821824, replyNumber=0, likeNumber=41, createdTime=2021-03-11, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fc520821824, moduleTitle=J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fc520821824)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301323, encodeId=190f1301323e4, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, objectType=article, longId=204329, objectId=16ec20432946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16ec20432946, replyNumber=0, likeNumber=32, createdTime=2020-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16ec20432946, moduleTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16ec20432946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301321, encodeId=4614130132182, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2020：礼来的LOXO-305在复发难治CLL/SLL中显示62％的缓解率, objectType=article, longId=204326, objectId=d24d20432640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24d20432640, replyNumber=0, likeNumber=0, createdTime=2020-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24d20432640, moduleTitle=ASH 2020：礼来的LOXO-305在复发难治CLL/SLL中显示62％的缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24d20432640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301322, encodeId=a415130132257, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）, objectType=article, longId=204325, objectId=737c20432583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=737c20432583, replyNumber=0, likeNumber=32, createdTime=2020-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=737c20432583, moduleTitle=ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=737c20432583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301320, encodeId=be5d130132086, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2020：Momelotinib治疗血小板计数较低的中/高危骨髓纤维化患者，已取得阳性结果, objectType=article, longId=204323, objectId=f15a204323fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15a204323fa, replyNumber=0, likeNumber=38, createdTime=2020-12-10, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15a204323fa, moduleTitle=ASH 2020：Momelotinib治疗血小板计数较低的中/高危骨髓纤维化患者，已取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15a204323fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301319, encodeId=223d1301319a2, content=<a href='/topic/show?id=38e32852fe' target=_blank style='color:#2F92EE;'>#ASH#</a>, objectTitle=ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳, objectType=article, longId=204260, objectId=d025204260e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d025204260e3, replyNumber=0, likeNumber=42, createdTime=2020-12-09, rootId=0, userName=kksonne, userId=39a0295, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d025204260e3, moduleTitle=ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d025204260e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASH

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#ASH# #米托蒽醌脂质体#

国际声音丨2023 ASH米托蒽醌脂质体多项血液领域研究成果精彩亮相！

2023-12-21发表于上海

kksonne (审核中...)

前往app查看评论内容

#ASH#

TCT 2022：新型Bashir导管或将成为治疗肺栓塞的利器

2022-09-19

kksonne (审核中...)

前往app查看评论内容

#ASH#

PLoS One：缘何瘦子也会得NASH-HCC？反式脂肪、胆固醇和果糖含量高的不健康饮食或是关键！

2022-08-28

kksonne (审核中...)

前往app查看评论内容

#ASH#

Chediak-Higashi综合征：症状与体征、病因、流行病学、诊断和治疗

2022-08-21

kksonne (审核中...)

前往app查看评论内容

#ASH#

FDA授予辉瑞Ervogastat/Clesacostat用于非酒精性脂肪性肝炎 (NASH) 的快速通道资格

2022-05-29

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2021：二线 Axicabtagene Cilouleucel 治疗复发/难治DLBCL，疗效更佳

2021-12-28

kksonne (审核中...)

前往app查看评论内容

#ASH#

武田在美国血液学会(ASH)第63届年会上发布可促进血液病和肿瘤患者治疗的新研究成果

2021-12-12

kksonne (审核中...)

前往app查看评论内容

#ASH#

Radiology：MRI，为NASH患者治疗反应的早期评估提供了强有力的预测指标！

2021-11-11

kksonne (审核中...)

前往app查看评论内容

#ASH#

NEJM：拉尼兰诺治疗NASH的疗效

2021-10-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

Efruxifermin (EFX) 治疗非酒精性脂肪性肝炎 (NASH)，FDA授予其“快速通道资格”

2021-10-22

kksonne (审核中...)

前往app查看评论内容

#ASH#

史密斯探测证实，BioFlash可检出空气中的SARS-CoV-2变异株，包括德尔塔和德尔塔+

2021-10-17

kksonne (审核中...)

前往app查看评论内容

#ASH#

50万人数据：预防心肌代谢性疾病只能看DASH和地中海饮食？中国饮食模式也能！

2021-09-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

JACC：DASH膳食与钠摄入量对心脏损伤/劳损/炎症生物标志物的影响

2021-06-04

kksonne (审核中...)

前往app查看评论内容

#ASH#

Pain Physician：Ashi针灸治疗 VS. 局部麻醉注射治疗腹肌筋膜疼痛综合征的疗效对比

2021-04-15

kksonne (审核中...)

前往app查看评论内容

#ASH#

J Ethnopharmacol：Ashwagandha根提取物可以提高睡眠质量，有助于管理失眠

2021-03-11

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2020：Calquence治疗MCL的长期疗效和耐受性

2020-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2020：礼来的LOXO-305在复发难治CLL/SLL中显示62％的缓解率

2020-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2020：抗CD117单克隆抗体JSP191用于治疗严重联合免疫缺陷病（SCID）

2020-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2020：Momelotinib治疗血小板计数较低的中/高危骨髓纤维化患者，已取得阳性结果

2020-12-10

kksonne (审核中...)

前往app查看评论内容

#ASH#

ASH 2020：亘喜生物BCMA/CD19双靶向CAR-T治疗复发或难治多发性骨髓瘤首次人体治疗数据惊艳

2020-12-09

科室
- - 订阅+
  - 更多科室
工具
服务